MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    eEF1A2 promotes cell survival and protects against MPP+-induced apoptotic neuronal death through the PI3K/Akt/mTOR pathway

    K. Khwanraj, P. Dharmasaroja, B. Morris (Ratchathewi, Thailand)

    Objective: To assess the correlation of eEF1A2 and PI3K/Akt/mTOR expression and investigate the pro-survival role of eEF1A2 in NG108-15 rodent neuroglioma cells. Background: Eukaryotic protein…
  • 2017 International Congress

    Exome sequencing in patients with impulse control disorders in Parkinson’s disease: a pilot study

    S. Prud'hon, F. Danjou, S. Bekadar, Y. Marie, A. Rastetter, J. Guégan, F. Cormier-Dequaire, S. Lesage, A. Brice, J.-c. Corvol (Paris, France)

    Objective: To identify genetic variants associated with impulse control disorders (ICD) in Parkinson’s disease (PD) Background: ICD is frequently associated with dopamine agonist (DA) therapy…
  • 2017 International Congress

    Alterations in lipid metabolism modify GBA1-mediated neurodegeneration in a Drosophila model of Parkinson’s disease

    M. Davis, R. Thomas, A. Germanos, S. Yu, B. Whitley, L. Pallanck (Seattle, WA, USA)

    Objective: To understand how glucocerebrosidase (GBA1) mutations increase susceptibility to Parkinson's disease (PD). Background: Our understanding of the pathogenesis PD remains limited, and currently no…
  • 2017 International Congress

    Longitudinal analysis of the relation of dopamine agonist use with impulse control disorders in Parkinson’s disease

    j.-c. corvol, F. Artaud, O. Rascol, F. Durif, P. Derkinderen, F. Bourdain, J.-P. Brandel, f. Pico, L. Lacomblez, C. Bonnet, D. Grabli, S. Klebe, G. Mangone, H. You, v. Mesnage, P.C. Lee, A. Brice, M. Vidailhet, F. Cormier-Dequaire, A. Elbaz (Paris, France)

    Objective: To investigate the longitudinal relationship between dopaminergic therapies and impulse control disorders (ICD) in PD. Background: ICD are frequently associated with dopaminergic therapy, particularly dopamine…
  • 2017 International Congress

    Predictive Ability of Clinical Timed Tests for Postural Instability and Gait Difficulty in Parkinson’s Disease

    M. Bryant, J.-G. Hou, F. Jamal, G. Jackson, C. Workman, E. Protas (Houston, TX, USA)

    Objective: To identify clinical determinants for postural instability and gait difficulty in persons with Parkinson's disease (PD). Background: Gait deficits and postural instability in persons…
  • 2017 International Congress

    Sports or no sports – is that the question in PD?

    M. Strothjohann, P. Kostopoulos, F. Weber (Bad Camberg, Germany)

    Objective: A multitude of risk factors or protective factors in developing Parkinson’s Disease (PD) are under discussion, as caffeine consumption or smoking ..  Background: Frequent physical activity…
  • 2017 International Congress

    Is There a Correlation Between Functional Capacity Upper Limbs and Falls Risk and Postural Instability in Parkinson’s Disease?

    T. Capato, R. RODRIGUES, E. Barbosa, M.E. Piemonte (SAO PAULO, Brazil)

    Objective: The goal of this study was to verify by a Brief Battery Functional Assessment (BBFA) the correlation between upper limb function skills with falls…
  • 2017 International Congress

    The Adult Spasticity International Registry (ASPIRE) Study: Treatment Utilization Patterns in Patients Treated for Both Upper and Lower Limb Spasticity

    G. Francisco, D. Bandari, G. Bavikatte, W. Jost, A. Manack Adams, J. Largent, A. Esquenazi (Houston, TX, USA)

    Objective: To examine the treatment patterns of onabotulinumtoxinA utilization in patients treated for upper and lower limb spasticity, in combination, from the ASPIRE study (1…
  • 2017 International Congress

    Tourettism associated with the Xq25 Microduplication Syndrome

    C. Spears, I. Malaty (Gainesville, FL, USA)

    Objective: To present a novel case of Tourettism emerging within the Xq25 microduplication syndrome. Background: Tourette syndrome (TS) is a childhood-onset neurobehavioral disorder hallmarked by…
  • 2017 International Congress

    Postural control is maintained after a 8-months period of exercise in people with Parkinson’s disease

    L. Gobbi, N. Rinaldi, P. Pelicioni, E. Lirani-Silva, L. Moraes, M. Pereira (Rio Claro, Brazil)

    Objective: Our aim was to investigate the effects of different long-lasting exercises programs on the postural control in people with Parkinson’s disease (PD). Background: Postural…
  • « Previous Page
  • 1
  • …
  • 112
  • 113
  • 114
  • 115
  • 116
  • …
  • 155
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley